ArticleClinical research in cardiology : official journal of the German Cardiac Society2011
Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010.
Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI.Heart and vessels · 2016Trial
- Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.BMJ (Clinical research ed.) · 2011Trial
- Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches.European heart journal. Acute cardiovascular care · 2012Article
- Update on the management of atrial fibrillation: anticoagulation and medical therapy.Current cardiology reports · 2011Review
- Acute study of clinical effectiveness of nesiritide in decompensated heart failure: nesiritide redux.Current heart failure reports · 2011Article
- Hotline update of clinical trials and registries presented at the American College of Cardiology Congress 2011.Clinical research in cardiology : official journal of the German Cardiac Society · 2011Article
- Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban.Mediators of inflammation · 2011Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article gives an overview on the late-breaking clinical trials in the field of cardiovascular medicine which were presented during the hotline sessions at the American Heart Association Congress, held in Chicago, USA, from 13 to 17th November 2010. The data have been presented by leading experts in the field with relevant positions in the trials. The summaries provided in the manuscript were generated from the oral presentations and the webcasts of the American Heart Association (Laufs in Clin Res Cardiol 97:1-11, 2008; Möllmann in Clin Res Cardiol 98:1-7, 2009). The following papers are discussed in alphabetical order: ACT, ADVANCE, ASCEND-HF, ASCOT-CRP, CLOSURE I, DEFINE, EMPHASIS-HF, GRAVITAS, P-OM3, RAFT, ROCKET-AF, SMART-AV, SYMPLICITY HTN-2, TELE-HF, TIM-HF.
Indexed as
Identifiers
21181176What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.